Offerpad Solutions (OPAD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 3, 2026, with shareholders voting on key proposals including director elections, auditor ratification, executive compensation, and a reverse stock split amendment.
Shareholders of record as of April 9, 2026, are entitled to vote, with each share of Class A common stock carrying one vote.
The Board recommends voting in favor of all proposals, including the election of two Class II directors, ratification of Deloitte & Touche LLP, approval of executive compensation, and the reverse stock split.
Voting matters and shareholder proposals
Proposals include electing Donna Corley and Tela Mathias as Class II directors, ratifying Deloitte & Touche LLP as auditor, approving executive compensation on an advisory basis, and amending the Certificate of Incorporation for a reverse stock split (1-for-5 to 1-for-50 ratio).
The reverse stock split aims to regain NYSE compliance and maintain listing requirements.
Shareholders may submit proposals for the 2027 meeting by December 2026, following specific bylaw requirements.
Board of directors and corporate governance
The Board consists of six members, with staggered three-year terms across three classes.
Four directors are deemed independent under NYSE rules.
Committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and responsibilities.
The Board regularly holds executive sessions and has a Lead Director to facilitate independent oversight.
Latest events from Offerpad Solutions
- All proposals, including director elections and reverse stock split, were approved.OPAD
AGM 20263 Jun 2026 - Q2 revenue up 9% YoY, gross margin at 8.7%, net loss narrowed, and asset-light services expanded.OPAD
Q2 20243 Jun 2026 - 2024 net loss improved 47% and asset-light services drove higher profitability.OPAD
Q4 20243 Jun 2026 - Q3 2024 revenue was $208.1M, net loss improved to $13.5M, and gross margin was 8.2%.OPAD
Q3 20243 Jun 2026 - Q1 2025 saw improved margins and record Renovate revenue despite ongoing market challenges.OPAD
Q1 20253 Jun 2026 - Revenue halved, but profitability and cash improved, with positive EBITDA targeted by year-end.OPAD
Q1 202630 Apr 2026 - Pre-effective amendment updates auditor consent and confirms offering structure for securities.OPAD
Registration filing27 Apr 2026 - Key votes include director elections, auditor ratification, and a reverse stock split for NYSE compliance.OPAD
Proxy filing22 Apr 2026 - Key votes include director elections, auditor ratification, and a reverse stock split proposal.OPAD
Proxy filing22 Apr 2026